J. Goldman & Co LP lifted its stake in Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) by 1.5% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 762,347 shares of the company's stock after purchasing an additional 11,263 shares during the quarter. J. Goldman & Co LP owned about 1.20% of Guardian Pharmacy Services worth $15,445,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. Deutsche Bank AG acquired a new stake in Guardian Pharmacy Services during the 4th quarter valued at approximately $129,000. Brown Advisory Inc. acquired a new position in Guardian Pharmacy Services during the fourth quarter valued at $32,294,000. BNP Paribas Financial Markets purchased a new stake in Guardian Pharmacy Services in the fourth quarter valued at $37,000. Northern Trust Corp acquired a new stake in Guardian Pharmacy Services during the 4th quarter worth about $1,479,000. Finally, MetLife Investment Management LLC purchased a new position in shares of Guardian Pharmacy Services during the 4th quarter valued at about $114,000.
Analyst Ratings Changes
Separately, Truist Financial lifted their price target on Guardian Pharmacy Services from $24.00 to $25.00 and gave the company a "buy" rating in a research report on Friday, April 11th.
Get Our Latest Research Report on GRDN
Guardian Pharmacy Services Trading Up 0.5 %
Shares of NYSE:GRDN opened at $25.61 on Friday. The business's 50 day moving average price is $22.13 and its 200-day moving average price is $21.56. Guardian Pharmacy Services, Inc. has a 1 year low of $14.16 and a 1 year high of $26.91.
Guardian Pharmacy Services Company Profile
(
Free Report)
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Further Reading
Want to see what other hedge funds are holding GRDN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Guardian Pharmacy Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.
While Guardian Pharmacy Services currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
